A new nationwide study led by the Keck School of Medicine of USC aims to examine how Type 1 diabetes impacts children's brain ...

If granted, Tremfya will be approved to treat children ages six and under with severe plaque psoriasis and children ages five ...

Yesintek is the latest Stelara biosimilar to gain FDA approval and it will be available in February 2025.

Seemal Desai, M.D., FAAD, discusses how managed care organizations can improve access to advanced vitiligo treatments through ...